Skip to main content
. 2016 Mar 2;13(2):439–449. doi: 10.1007/s13311-016-0424-8

Table 2.

Characteristics and differential scanning calorimetry of 4 nimodipine–poly(DL-lactide-co-glycolide) formulations after storage for 30 days

Number Storage condition (°C) Average drug content (weight %) Encapsulation efficiency (%) Particle size (μm) Drug purity (%) Tg (°C) Main melt (°C) Second melt (°C)
00447-098 4 61.2 94.2 ∀ 4.7 74.5 99.5 34.1 126.1 No peak
00447-098 25 63.2 97.2 ∀ 2.9 77.8 99.6 42.1 126.5 113.8 (tiny peak)
00447-098 30–35 66.2 101.8 ∀ 2.1 95.7 99.8 49 125.8 113.5 (tiny peak)
00447-102 4 62.8 96.6 ∀ 3.3 63.5 99.4 34.6 125 114.2 (tiny peak)
00447-102 25 57.6 88.6 ∀ 8.3 64.9 99.6 38 125 114.6
00447-102 30–35 65 100.1 ∀ 0.5 70.3 99.8 48.8 125 114.6
00447-108 4 63 96.9 ∀ 9.5 79.3 99.7 35 126.5 No peak
00447-108 25 62.8 96.6 ∀ 10.4 76.8 99.8 39.6 126.1 No peak
00447-108 30–35 68 104.6 ∀ 1.6 79.8 99.8 49.44 126.5 No peak
00447-110 4 52.1 104.3 ∀ 2.5 59.2 98.1 19.6 122 112.3
00447-110 25 45.5 91.0 ∀ 127.4 99.7 33.9 112.7 122.4